Victory Capital Management Inc. Has $1.17 Million Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Victory Capital Management Inc. reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 36.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,836 shares of the medical instruments supplier's stock after selling 5,165 shares during the period. Victory Capital Management Inc. owned about 0.16% of Mesa Laboratories worth $1,165,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Principal Financial Group Inc. raised its stake in shares of Mesa Laboratories by 21.8% during the 3rd quarter. Principal Financial Group Inc. now owns 35,107 shares of the medical instruments supplier's stock worth $4,559,000 after purchasing an additional 6,292 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Mesa Laboratories during the 3rd quarter worth about $449,000. Charles Schwab Investment Management Inc. raised its stake in shares of Mesa Laboratories by 38.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 62,609 shares of the medical instruments supplier's stock worth $8,130,000 after purchasing an additional 17,450 shares in the last quarter. Eagle Asset Management Inc. raised its stake in shares of Mesa Laboratories by 10.9% during the 3rd quarter. Eagle Asset Management Inc. now owns 165,955 shares of the medical instruments supplier's stock worth $19,722,000 after purchasing an additional 16,293 shares in the last quarter. Finally, The Manufacturers Life Insurance Company purchased a new stake in shares of Mesa Laboratories during the 3rd quarter worth about $265,000. 90.60% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Mesa Laboratories Stock Up 1.3 %

Shares of MLAB traded up $1.64 during midday trading on Friday, reaching $125.14. 73,066 shares of the stock were exchanged, compared to its average volume of 36,934. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. The company has a market cap of $680.01 million, a price-to-earnings ratio of -2.71 and a beta of 0.82. The firm has a 50 day simple moving average of $137.90 and a 200-day simple moving average of $129.12. Mesa Laboratories, Inc. has a 12-month low of $83.68 and a 12-month high of $155.12.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. Research analysts forecast that Mesa Laboratories, Inc. will post 8 EPS for the current year.

Mesa Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, February 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend was Friday, February 28th. Mesa Laboratories's dividend payout ratio is -1.38%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.